Currently, the mechanism by which SNHG7 influences AML remains unclear. Shi Jian et al. and Saeed Hassani et al. have confirmed through clinical sample experiments and statistical analyses that SNHG7 is an independent prognostic factor for poor outcomes in AML (Shi et al., 2020b; Hassani et al., 2024). Here, SNHG7 is linked to acute myeloid leukemia.